Central Giant Cell Granuloma (CGCG) is a benign but potentially aggressive lesion that typically occurs in the jawbones, particularly in the mandible and maxilla. It is characterized by the presence of giant cells, which are large cells formed by the fusion of macrophages. CGCG can cause significant bone destruction and deformity, especially if it is aggressive in nature. The exact cause of CGCG remains unknown, but it is more commonly seen in children and young adults.
Central Giant Cell Granuloma in Children
- Overview
- Symptoms
- Causes
- Diagnosis
- Treatment Options
- Patient Success Stories
- Living with Central Giant Cell Granuloma
- Contact Us
Overview
Symptoms
Common signs of Central Giant Cell Granuloma include:
- Swelling or a noticeable mass in the jaw area
- Pain or discomfort in the affected region
- Tooth displacement or mobility
- Numbness or tingling in nearby areas
- Rapid growth of the lesion in aggressive cases
Causes
The exact causes of CGCG are not well understood, but potential factors may include:
- Genetic predispositions
- Previous trauma to the jaw
- Hormonal influences, as it often appears in younger individuals
Diagnosis
Diagnosing CGCG typically involves:
- Physical Examination: Assessment of symptoms and visual inspection of the lesion.
- Imaging Tests: X-rays, CT scans, or MRIs to determine the size and extent of the lesion.
- Biopsy: A small sample of tissue may be taken for histopathological analysis to confirm the diagnosis.
Treatment Options
Treatment for Central Giant Cell Granuloma varies depending on whether the lesion is aggressive or non-aggressive. Options include:
- Surgical Approaches:
- Curettage: Removal of the lesion using a curette, often with good outcomes for smaller lesions.
- Resection: More extensive surgeries like segmental mandibulectomy or maxillectomy may be necessary for larger or aggressive lesions.
- Non-Surgical Treatments:
- Intralesional Corticosteroids: Injections that can reduce lesion size and are often used before surgery.
- Calcitonin Therapy: Administered via injections or nasal sprays to inhibit bone resorption.
- Denosumab: A monoclonal antibody that targets RANK/RANKL pathways, showing promise in managing aggressive cases.
Patient Success Stories
At Gertrude’s Children’s Hospital, we are committed to providing the best possible care for children with Central Giant Cell Granuloma. Here’s why families trust us:
“After my child was diagnosed with CGCG, we were anxious about treatment options. The team at Gertrude's Children's Hospital guided us through every step, ensuring we understood the process. The surgery went smoothly, and my child has made a full recovery.”
Sarahparent of a CGCG patient
Central Giant Cell Granuloma in Children
Untreated CGCG can lead to significant bone loss, deformity, and complications such as tooth displacement.
Recovery time varies but generally ranges from a few weeks to several months depending on the extent of surgery.
Yes, there is a possibility of recurrence, particularly with aggressive forms; regular follow-up appointments are essential.
Contact Us
If you suspect your child may have Central Giant Cell Granuloma or if you have any concerns regarding their oral health, we encourage you to schedule an appointment with our expert team. We are dedicated to providing comprehensive care tailored to your child’s needs.
Contact us today to learn more about our Central Giant Cell Granuloma treatment options.
- Phone: +254-709-529-000, +254-733-645-000
- Email: Info@gerties.org
- Online Scheduling: https://www.gerties.org/book-appointment/
